Eli Lilly and Company announced agreements to acquire three companies focused on vaccine development for infectious disease. ...

Three vaccine candidates are being fast-tracked to target the Ebola species spreading in Central Africa. Big organizations and companies are behind the effort, but logistics are complicated.

Novavax ( (NVAX)) has released its Q3 earnings. Here is a breakdown of the information Novavax presented to its investors. Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology ...

Eli Lilly and Company is pivoting significantly toward infectious disease prevention by executing agreements to buy three ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, ...

J&J's Rybrevant and cancer vaccines are showing benefit During the American Society of Clinical Oncology (ASCO) meeting 2026, ...

Since early 2020, unprecedented efforts have been devoted to design, test and deploy vaccines that can safely elicit robust and durable immunity against SARS-CoV-2. Platform technologies range from ...